ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.425
-0.026 (-1.79%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.026 -1.79% 1.425 1.402 1.448 1.42 1.41 1.42 3,614,132 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0059 -2.39 16.1M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.45p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £16.10 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.39.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 2151 to 2165 of 13425 messages
Chat Pages: Latest  93  92  91  90  89  88  87  86  85  84  83  82  Older
DateSubjectAuthorDiscuss
02/4/2020
00:54
You are 100% right OnTarget.
scaramouche1941
01/4/2020
18:06
And talking of jockeys how many companies of this size have the likes of Feldmann and Shepard on board?
on target
01/4/2020
17:36
"they cannot move into clinic (Inflection point) with a few bucks they raised so far."

Exactly, which is why they are trying to get an in-licencing deal with 'globalco'.

on target
01/4/2020
17:29
Yes, they started a collaboration in May 2018. They commenced negotiations in 2019. And they are most likely moving forward but slower than anyone expected, partially because of the pandemic.
Hemo is poorly capitalized and cannot increase its value rapidly. They are trying to do it based on their announcements and videos but the bottom line is they cannot move into clinic (Inflection point) with a few bucks they raised so far. All known to me startups that fly raised 10-500 times more money than Hemo over its lifetime, upfront. That is the key. I am mesmerized by the mere fact that Hemo is still in business and moving forward! This Dr. must be a genius or a saint. And their team is amazing - watch their videos. I would say that Hemo is a classic case of a company where the “jockey” is much more important than the “horse”.

scaramouche1941
01/4/2020
17:08
A few months? It's been nearly 2 years scaramouche!

May 2018:



And this is from January 2019:

"discussion regarding licensing deal expected to commence in early 2019"

on target
01/4/2020
17:06
Please see who started Sitryx and how much they invested into Sitryx over two years here:
hxxp://www.sitryx.com/investors/

To get a deal like the one that was announced it took Sitryx more than two years after their partner invested in them.
Hemo cannot make a deal in a few months. It is simply unreasonable to expect this from them given the amount of investment they got and the complexity of the situation.

scaramouche1941
01/4/2020
16:57
Deals are still being done, this one today worth $880m with a $50m upfront payment



"Sitryx will carry out drug discovery, while Lilly will fund and perform clinical development and commercial activities."

Yes, exactly applicable to HEMO and exactly what we are waiting for.

Here we sit with a £4m market cap. Please get on with it Vladislav!

on target
01/4/2020
09:02
unless they announce who the globalco is and what they are going to do with them this is finished.

personally don't think they've got an agreement with anyone.

purple11
01/4/2020
08:38
basketcase stock.
purple11
31/3/2020
15:08
globalco gossip

shukan lse
Redmond says the lab is not setup for Covid-19 - but what Pharma are using the hemo mice for antibodies research and who is partnered with Hemogenyx-
We will find out soon enough

purple11
30/3/2020
16:57
Pathetic and puerile..
lionheart69uk1
30/3/2020
14:30
It's new ISA season next week so there's going to be a lot of money looking for bargains I would guess, coupled with an end to tax loss selling. Therefore this week could be a good time to dip toes into any such bargains if you can?
on target
30/3/2020
14:23
Got rid of my holding weeks ago. So when do you think it might be worth dipping my toes back in? Was thinking if it falls below 1p but that might simply be the beginning of the end. Plenty of other cheap stocks in the current market to attract my interest.
lionheart69uk1
30/3/2020
13:58
I just heard on sky news that Johnson and Johnson are working on a vaccine they hope to produce later this year.....I wonder ????
johntopdog
30/3/2020
12:14
Purple still whinging like a big girl
johntopdog
Chat Pages: Latest  93  92  91  90  89  88  87  86  85  84  83  82  Older

Your Recent History